Plenary 2: Proffered Paper Abstract Session
Monday, August 13, 2018 |
2:15 PM - 3:45 PM |
Hall M (Ground Floor) |
Speaker
Dr Kelly Hosking
Director of Sexual Health Blood Borne Viruses
NT Health & Menzies School of Health Research
Big Mob, Big Job - Hepatitis B Sero-Coding The Top End
2:15 PM - 2:30 PMBiography
Kelly Hosking is a registered nurse and has completed a Master of Public Health. She has worked both Internationally and in Aboriginal and Torres Strait Island communities in public health and primary health care. She currently works with Remote Primary Health Care Branch, NT, as the Continuous Quality Improvement Facilitator.
Ms Kathryn Stewart
Program Manager - Hepatitis B
Hepatitis Australia
Hepatitis B Community Partnerships - Dancing with Cinderella
2:30 PM - 2:45 PMBiography
Kathryn Stewart is the Hepatitis B Program Manager at Hepatitis Australia, where she has worked since 2015. Most recently, she has been instrumental in developing and implementing the national Hepatitis B Community Education Project (HBCEP). The HBCEP is the first systematic community education response to hepatitis B in Australia.
A/Prof Gail Matthews
Program Head, Therapeutic and Vaccine Research Program, Department Head of Infectious Disease Physician
The Kirby Institute, UNSW Sydney
Evaluation Of The Xpert® Hcv Fingerstick Viral Load Point-Of-Care-Assay
2:45 PM - 3:00 PMBiography
Dr Tanya Applegate leads the research laboratory team in the Viral Hepatitis and Clinical Research Program at the Kirby Institute, UNSW Sydney and. Tanya’s interests include HCV translational research, focusing on the development and implementation of molecular diagnostics to improve HCV health care among marginalised populations and resource limited settings.
Dr Jenny Iversen
Senior Lecturer
The Kirby Institute
Hepatitis C Virus Infection Among People Who Inject Drugs In Australia: Monitoring Exposure, Treatment Uptake And Viraemic Prevalence
3:00 PM - 3:15 PMBiography
Jenny oversees coordination of surveillance projects within the Viral Hepatitis Epidemiology and Prevention Program at the Kirby Institute. Her current Australian projects include the Australian NSP Survey, the NSW NSP Enhanced Data Collection and the NSP National Minimum Data Collection.
Dr Evan Cunningham
Postdoctorral Fellow
The Kirby Institute, UNSW
Adherence To Sofosbuvir And Velpatasvir Among People With Chronic Hcv Infection And Recent Injection Drug Use: The Simplify Study
3:15 PM - 3:30 PMBiography
Evan obtained his PhD a the University of New South Wales in Sydney looking at HCV transmission and treatment among people who inject drugs. He is is now working as a postdoctoral fellow in the Viral Hepatitis research Program at the Kirby Institute in Sydney.
Doctor Jake Rance
Research Fellow
Unsw Sydney
The Matter Of Reinfection: Attitudes Among Australian Prisoners From The SToP-C Study
3:30 PM - 3:45 PMBiography
Jake joined the Centre for Social Research in Health (CSRH) following nearly a decade working in harm reduction services in Sydney’s Kings Cross. He has a longstanding interest in the potential of qualitative research to challenge the stigmatising and pathologising accounts commonplace within conventional explanations of injecting drug use.
Chair
Scott Bowden
Honorary
The Doherty
Vanessa Towell
Program Manager
WHO Collaborating Centre For Viral Hepatitis